Vyome Holdings (HIND) Tax Provisions (2020 - 2025)
Vyome Holdings (HIND) posted quarterly Tax Provisions of $8000.0 for Q2 2025, down 46.67% year-over-year from $15000.0 in Q2 2024, and up 14.29% quarter-over-quarter from $7000.0 in Q1 2025.
Vyome Holdings (HIND) Tax Provisions (2020 - 2025) Analysis & Trends
Vyome Holdings' Tax Provisions history runs 6 years deep, the most recent figure standing at $8000.0 for Q2 2025.
- In Q2 2025, Tax Provisions fell 46.67% year-over-year to $8000.0; the TTM figure through Jun 2025 stood at $26000.0 (down 58.73% YoY), while the FY2024 annual figure was $39000.0, down 25.0% from the prior year.
- Tax Provisions for Q2 2025 stood at $8000.0, up from $7000.0 in the prior quarter.
- The five-year high for Tax Provisions was $309000.0 in Q4 2022, with the low at -$363000.0 in Q3 2022.
- The 5-year median for Tax Provisions is $8500.0 (2022), against an average of $5722.2.
- Peak annual rise in Tax Provisions reached 2675.0% in 2022, while the deepest fall reached 1110.0% in 2022.
- Vyome Holdings' Tax Provisions stood at -$12000.0 in 2021, then jumped by 2675.0% to $309000.0 in 2022, then plunged by 89.97% to $31000.0 in 2023, then slumped by 83.87% to $5000.0 in 2024, then soared by 60.0% to $8000.0 in 2025.
- Business Quant data shows HIND's Tax Provisions at $8000.0 in Q2 2025, $7000.0 in Q1 2025, and $5000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Vyome Holdings | 16.07 Mn | 8.18 Mn | 11,658.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 8,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | 31,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 14,000.00 |
| Dec 31, 2022 | 309,000.00 |
| Sep 30, 2022 | -363,000.00 |
| Jun 30, 2022 | 9,000.00 |
| Mar 31, 2022 | 30,000.00 |
| Dec 31, 2021 | -12,000.00 |
| Sep 30, 2021 | -30,000.00 |
| Jun 30, 2021 | 28,000.00 |
| Mar 31, 2021 | 25,000.00 |
| Dec 31, 2020 | 109,000.00 |
| Sep 30, 2020 | -39,000.00 |